Showing results (1-10 of 490) with videos related to
Sort By:
Pageof 49
Cancer|June 7, 2005
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma: a prospectively planned combined survival analysis of two multicenter trialsAnthony Howell, John Pippen, Richard M Elledge, et al.Cancer|July 23, 2003
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trialsJohn F R Robertson, C Kent Osborne, Anthony Howell, et al.Bulletin Du Cancer|March 13, 2002
[Standards, Options and Recommendations for non metastatic breast cancer patients]Louis MauriacSeminars in Oncology|September 27, 2003
Aromatase inhibitors in early breast cancer treatmentLouis Mauriac, Ian SmithBreast (Edinburgh, Scotland)|September 20, 2005
When will more useful predictive factors be ready for use?Louis Mauriac, Marc Debled, Gaëtan MacGroganThe Journal of Steroid Biochemistry and Molecular Biology|July 16, 2005
Aromatase inhibitors: future directionsC Kent Osborne, Rachel SchiffBreast (Edinburgh, Scotland)|December 9, 2003
Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancerC Kent Osborne, Rachel SchiffBreast Cancer Research : BCR|September 20, 2005
Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancerRachel Schiff, C Kent OsborneAnnual Review of Medicine|October 5, 2010
Mechanisms of endocrine resistance in breast cancerC Kent Osborne, Rachel SchiffBreast Cancer Research and Treatment|November 26, 2008
Activity of fulvestrant versus exemestane in advanced breast cancer patients with or without visceral metastases: data from the EFECT trialLouis Mauriac, Gilles Romieu, José BinesPageof 49